Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Jan;55(1):1–5. doi: 10.1038/bjc.1987.1

Human preleukaemia: do we have a model?

A Jacobs
PMCID: PMC2001557  PMID: 3545274

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abkowitz J. L., Fialkow P. J., Niebrugge D. J., Raskind W. H., Adamson J. W. Pancytopenia as a clonal disorder of a multipotent hematopoietic stem cell. J Clin Invest. 1984 Jan;73(1):258–261. doi: 10.1172/JCI111199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amato D., Khan N. R. Erythroid burst formation in cultures of bone marrow and peripheral blood from patients with refractory anemia. Acta Haematol. 1983;70(1):1–10. doi: 10.1159/000206682. [DOI] [PubMed] [Google Scholar]
  3. BLOCK M., JACOBSON L. O., BETHARD W. F. Preleukemic acute human leukemia. J Am Med Assoc. 1953 Jul 11;152(11):1018–1028. doi: 10.1001/jama.1953.03690110032010. [DOI] [PubMed] [Google Scholar]
  4. Barlogie B., Raber M. N., Schumann J., Johnson T. S., Drewinko B., Swartzendruber D. E., Göhde W., Andreeff M., Freireich E. J. Flow cytometry in clinical cancer research. Cancer Res. 1983 Sep;43(9):3982–3997. [PubMed] [Google Scholar]
  5. Barosi G., Cazzola M., Morandi S., Stefanelli M., Perugini S. Estimation of ferrokinetic parameters by a mathematical model in patients with primary acquired sideroblastic anaemia. Br J Haematol. 1978 Jul;39(3):409–423. doi: 10.1111/j.1365-2141.1978.tb01112.x. [DOI] [PubMed] [Google Scholar]
  6. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982 Jun;51(2):189–199. [PubMed] [Google Scholar]
  7. Betsholtz C., Johnsson A., Heldin C. H., Westermark B., Lind P., Urdea M. S., Eddy R., Shows T. B., Philpott K., Mellor A. L. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature. 1986 Apr 24;320(6064):695–699. doi: 10.1038/320695a0. [DOI] [PubMed] [Google Scholar]
  8. Blick M., Westin E., Gutterman J., Wong-Staal F., Gallo R., McCredie K., Keating M., Murphy E. Oncogene expression in human leukemia. Blood. 1984 Dec;64(6):1234–1239. [PubMed] [Google Scholar]
  9. Boehme W. M., Piira T. A., Kurnick J. E., Bethlenfalvay N. C. Acquired hemoglobin H in refractor sideroblastic anemia. A preleukemic marker. Arch Intern Med. 1978 Apr;138(4):603–606. [PubMed] [Google Scholar]
  10. Boettiger D., Dexter T. M. Altered stem cell (CFU-S) function following infection of hematopoietic cells with a virus carrying V-src. Blood. 1986 Feb;67(2):398–405. [PubMed] [Google Scholar]
  11. Boogaerts M. A., Nelissen V., Roelant C., Goossens W. Blood neutrophil function in primary myelodysplastic syndromes. Br J Haematol. 1983 Oct;55(2):217–227. doi: 10.1111/j.1365-2141.1983.tb01241.x. [DOI] [PubMed] [Google Scholar]
  12. Bos J. L., Toksoz D., Marshall C. J., Verlaan-de Vries M., Veeneman G. H., van der Eb A. J., van Boom J. H., Janssen J. W., Steenvoorden A. C. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. 1985 Jun 27-Jul 3Nature. 315(6022):726–730. doi: 10.1038/315726a0. [DOI] [PubMed] [Google Scholar]
  13. Bradshaw T. K. Cell transformation: the role of oncogenes and growth factors. Mutagenesis. 1986 Mar;1(2):91–97. doi: 10.1093/mutage/1.2.91. [DOI] [PubMed] [Google Scholar]
  14. Carroll A. J., Poon M. C., Robinson N. C., Crist W. M. Sideroblastic anemia associated with thrombocytosis and a chromosome 3 abnormality. Cancer Genet Cytogenet. 1986 Jun;22(2):183–187. doi: 10.1016/0165-4608(86)90205-0. [DOI] [PubMed] [Google Scholar]
  15. Clark R. E., Hoy T. G., Jacobs A. Granulocyte and monocyte surface membrane markers in the myelodysplastic syndromes. J Clin Pathol. 1985 Mar;38(3):301–304. doi: 10.1136/jcp.38.3.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Clark R., Peters S., Hoy T., Smith S., Whittaker K., Jacobs A. Prognostic importance of hypodiploid hemopoietic precursors in myelodysplastic syndromes. N Engl J Med. 1986 Jun 5;314(23):1472–1475. doi: 10.1056/NEJM198606053142302. [DOI] [PubMed] [Google Scholar]
  17. Coiffier B., Adeleine P., Viala J. J., Bryon P. A., Fière D., Gentilhomme O., Vuvan H. Dysmyelopoietic syndromes. A search for prognostic factors in 193 patients. Cancer. 1983 Jul 1;52(1):83–90. doi: 10.1002/1097-0142(19830701)52:1<83::aid-cncr2820520117>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  18. Deuel T. F., Huang J. S. Roles of growth factor activities in oncogenesis. Blood. 1984 Nov;64(5):951–958. [PubMed] [Google Scholar]
  19. Duesberg P. H. Activated proto-onc genes: sufficient or necessary for cancer? Science. 1985 May 10;228(4700):669–677. doi: 10.1126/science.3992240. [DOI] [PubMed] [Google Scholar]
  20. Ferraris A. M., Broccia G., Meloni T., Canepa L., Sessarego M., Gaetani G. F. Clonal origin of cells restricted to monocytic differentiation in acute nonlymphocytic leukemia. Blood. 1984 Oct;64(4):817–820. [PubMed] [Google Scholar]
  21. Fohlmeister I., Fischer R., Mödder B., Rister M., Schaefer H. E. Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features. J Clin Pathol. 1985 Nov;38(11):1218–1224. doi: 10.1136/jcp.38.11.1218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Fohlmeister I., Fischer R., Schaefer H. E. Preleukemic myelodysplastic syndromes (MDS): pathogenetical considerations based on retrospective clinicomorphological sequential studies. Anticancer Res. 1985 Mar-Apr;5(2):179–188. [PubMed] [Google Scholar]
  23. Foucar K., Langdon R. M., 2nd, Armitage J. O., Olson D. B., Carroll T. J., Jr Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases. Cancer. 1985 Aug 1;56(3):553–561. doi: 10.1002/1097-0142(19850801)56:3<553::aid-cncr2820560323>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  24. Frisch B., Bartl R. Bone marrow histology in myelodysplastic syndromes. Scand J Haematol Suppl. 1986;45:21–37. doi: 10.1111/j.1600-0609.1986.tb00840.x. [DOI] [PubMed] [Google Scholar]
  25. Green A. R., Wyke J. A. Anti-oncogenes. A subset of regulatory genes involved in carcinogenesis? Lancet. 1985 Aug 31;2(8453):475–477. doi: 10.1016/s0140-6736(85)90404-0. [DOI] [PubMed] [Google Scholar]
  26. Greenberg P. L., Mara B. The preleukemic syndrome: correlation of in vitro parameters of granulopoiesis with clinical features. Am J Med. 1979 Jun;66(6):951–958. doi: 10.1016/0002-9343(79)90450-9. [DOI] [PubMed] [Google Scholar]
  27. Hast R., Reizenstein P. Studies on human preleukaemia. I. Erythroblast and iron kinetics in aregenerative anaemia with hypercellular bone marrow. Scand J Haematol. 1977 Oct;19(4):347–354. [PubMed] [Google Scholar]
  28. Hirai H., Tanaka S., Azuma M., Anraku Y., Kobayashi Y., Fujisawa M., Okabe T., Urabe A., Takaku F. Transforming genes in human leukemia cells. Blood. 1985 Dec;66(6):1371–1378. [PubMed] [Google Scholar]
  29. Huebner K., Isobe M., Croce C. M., Golde D. W., Kaufman S. E., Gasson J. C. The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q- anomaly. Science. 1985 Dec 13;230(4731):1282–1285. doi: 10.1126/science.2999978. [DOI] [PubMed] [Google Scholar]
  30. Jacobs A. Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J Clin Pathol. 1985 Nov;38(11):1201–1217. doi: 10.1136/jcp.38.11.1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Jacobs R. H., Cornbleet M. A., Vardiman J. W., Larson R. A., Le Beau M. M., Rowley J. D. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood. 1986 Jun;67(6):1765–1772. [PubMed] [Google Scholar]
  32. Juvonen E., Partanen S., Knuutila S., Ruutu T. Megakaryocyte colony formation by bone marrow progenitors in myelodysplastic syndromes. Br J Haematol. 1986 Jun;63(2):331–334. doi: 10.1111/j.1365-2141.1986.tb05556.x. [DOI] [PubMed] [Google Scholar]
  33. Karsdorf A., Dresch C., Metral J., Najean Y. Prognostic value of the combined suicide level of granulocyte progenitors and the labelling index of precursors in preleukemic states and oligoblastic leukemias. Leuk Res. 1983;7(2):279–286. doi: 10.1016/0145-2126(83)90018-8. [DOI] [PubMed] [Google Scholar]
  34. Klein G., Klein E. Evolution of tumours and the impact of molecular oncology. Nature. 1985 May 16;315(6016):190–195. doi: 10.1038/315190a0. [DOI] [PubMed] [Google Scholar]
  35. Knudson A. G., Jr Genetic predisposition to cancer. Cancer Detect Prev. 1984;7(1):1–8. [PubMed] [Google Scholar]
  36. Knuutila S., Teerenhovi L., Borgström G. H. Chromosome instability is associated with hypodiploid clones in myelodysplastic syndromes. Hereditas. 1984;101(1):19–30. doi: 10.1111/j.1601-5223.1984.tb00444.x. [DOI] [PubMed] [Google Scholar]
  37. Krontiris T. G., DiMartino N. A., Colb M., Mitcheson H. D., Parkinson D. R. Human restriction fragment length polymorphisms and cancer risk assessment. J Cell Biochem. 1986;30(4):319–329. doi: 10.1002/jcb.240300405. [DOI] [PubMed] [Google Scholar]
  38. Labal de Vinuesa M., Larripa I., Mudry de Pargament M., Brieux de Salum S. Heterochromatic variants and their association with neoplasias. II. Preleukemic states. Cancer Genet Cytogenet. 1985 Jan 1;14(1-2):31–35. doi: 10.1016/0165-4608(85)90212-2. [DOI] [PubMed] [Google Scholar]
  39. Land H., Parada L. F., Weinberg R. A. Cellular oncogenes and multistep carcinogenesis. Science. 1983 Nov 18;222(4625):771–778. doi: 10.1126/science.6356358. [DOI] [PubMed] [Google Scholar]
  40. Le Beau M. M., Westbrook C. A., Diaz M. O., Larson R. A., Rowley J. D., Gasson J. C., Golde D. W., Sherr C. J. Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders. Science. 1986 Feb 28;231(4741):984–987. doi: 10.1126/science.3484837. [DOI] [PubMed] [Google Scholar]
  41. Lintula R., Rasi V., Ikkala E., Borgström G. H., Vuopio P. Platelet function in preleukaemia. Scand J Haematol. 1981 Jan;26(1):65–71. doi: 10.1111/j.1600-0609.1981.tb01626.x. [DOI] [PubMed] [Google Scholar]
  42. Maldonado J. E., Pierre R. V. The platelets in preleukemia and myelomonocytic leukemia. Ultrastructural cytochemistry and cytogenetics. Mayo Clin Proc. 1975 Oct;50(10):573–587. [PubMed] [Google Scholar]
  43. Milner G. R., Testa N. G., Geary C. G., Dexter T. M., Muldal S., MacIver J. E., Lajtha L. G. Bone marrow culture studies in refractory cytopenia and 'smouldering leukaemia'. Br J Haematol. 1977 Feb;35(2):251–261. doi: 10.1111/j.1365-2141.1977.tb00582.x. [DOI] [PubMed] [Google Scholar]
  44. Montecucco C., Riccardi A., Traversi E., Danova M., Ucci G., Mazzini G., Giordano P. Flow cytometric DNA content in myelodysplastic syndromes. Cytometry. 1983 Nov;4(3):238–243. doi: 10.1002/cyto.990040308. [DOI] [PubMed] [Google Scholar]
  45. Nicola N. A., Metcalf D. The colony-stimulating factors and myeloid leukaemia. Cancer Surv. 1985;4(4):789–815. [PubMed] [Google Scholar]
  46. Nowell P. C. Cytogenetics of preleukemia. Cancer Genet Cytogenet. 1982 Mar;5(3):265–278. doi: 10.1016/0165-4608(82)90034-6. [DOI] [PubMed] [Google Scholar]
  47. Peters S. W., Clark R. E., Hoy T. G., Jacobs A. DNA content and cell cycle analysis of bone marrow cells in myelodysplastic syndromes (MDS). Br J Haematol. 1986 Feb;62(2):239–245. doi: 10.1111/j.1365-2141.1986.tb02927.x. [DOI] [PubMed] [Google Scholar]
  48. Prchal J. T., Throckmorton D. W., Carroll A. J., 3rd, Fuson E. W., Gams R. A., Prchal J. F. A common progenitor for human myeloid and lymphoid cells. Nature. 1978 Aug 10;274(5671):590–591. doi: 10.1038/274590a0. [DOI] [PubMed] [Google Scholar]
  49. Raskind W. H., Tirumali N., Jacobson R., Singer J., Fialkow P. J. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood. 1984 Jun;63(6):1318–1323. [PubMed] [Google Scholar]
  50. Ruutu T., Partanen S., Lintula R., Teerenhovi L., Knuutila S. Erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes. Scand J Haematol. 1984 Apr;32(4):395–402. doi: 10.1111/j.1600-0609.1984.tb00695.x. [DOI] [PubMed] [Google Scholar]
  51. Sachs L. Control of growth and normal differentiation in leukemic cells: regulation of the developmental program and restoration of the normal phenotype in myeloid leukemia. J Cell Physiol Suppl. 1982;1:151–164. doi: 10.1002/jcp.1041130423. [DOI] [PubMed] [Google Scholar]
  52. Schofield K. P., Stone P. C., Kelsey P., Leyland M. J., Stuart J. Quantitative cytochemistry of blood neutrophils in myelodysplastic syndromes and chronic granulocytic leukaemia. Cell Biochem Funct. 1983 Jul;1(2):92–96. doi: 10.1002/cbf.290010209. [DOI] [PubMed] [Google Scholar]
  53. Scott C. S., Cahill A., Bynoe A. G., Ainley M. J., Hough D., Roberts B. E. Esterase cytochemistry in primary myelodysplastic syndromes and megaloblastic anaemias: demonstration of abnormal staining patterns associated with dysmyelopoiesis. Br J Haematol. 1983 Nov;55(3):411–418. doi: 10.1111/j.1365-2141.1983.tb02155.x. [DOI] [PubMed] [Google Scholar]
  54. Seigneurin D., Hollard D. Use of the tritiated thymidine-labelling index of the myeloblast-promyelocyte pool for the identification of the leukemic population in oligoblastic leukemia. Acta Haematol. 1981;66(3):181–186. doi: 10.1159/000207117. [DOI] [PubMed] [Google Scholar]
  55. Sherr C. J., Rettenmier C. W., Sacca R., Roussel M. F., Look A. T., Stanley E. R. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell. 1985 Jul;41(3):665–676. doi: 10.1016/s0092-8674(85)80047-7. [DOI] [PubMed] [Google Scholar]
  56. Sokal G., Michaux J. L., van den Berghe H. The karyotype in refractory anaemia and pre-leukaemia. Clin Haematol. 1980 Feb;9(1):129–139. [PubMed] [Google Scholar]
  57. Spitzer G., Verma D. S., Dicke K. A., Smith T., McCredie K. B. Subgroups of oligoleukemia as identified by in vitro agar culture. Leuk Res. 1979;3(1):29–39. doi: 10.1016/0145-2126(79)90006-7. [DOI] [PubMed] [Google Scholar]
  58. Todd W. M., Pierre R. V. Preleukaemia: a long-term prospective study of 326 patients. Scand J Haematol Suppl. 1986;45:114–120. doi: 10.1111/j.1600-0609.1986.tb00855.x. [DOI] [PubMed] [Google Scholar]
  59. Tomonaga M., Tomonaga Y., Kusano M., Ichimaru M. Sequential karyotypic evolutions and bone marrow aplasia preceding acute myelomonocytic transformation from myelodysplastic syndrome. Br J Haematol. 1984 Sep;58(1):53–60. doi: 10.1111/j.1365-2141.1984.tb06058.x. [DOI] [PubMed] [Google Scholar]
  60. Tricot G., Boogaerts M. A., De Wolf-Peeters C., Van den Berghe H., Verwilghen R. L. The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations. Br J Haematol. 1985 Apr;59(4):659–670. doi: 10.1111/j.1365-2141.1985.tb07361.x. [DOI] [PubMed] [Google Scholar]
  61. Valentine W. N., Konrad P. N., Paglia D. E. Dyserythropoiesis, refractory anemia, and "preleukemia:" metabolic features of the erythrocytes. Blood. 1973 Jun;41(6):857–875. [PubMed] [Google Scholar]
  62. Verma D. S., Spitzer G., Dicke K. A., McCredie K. B. In vitro agar culture patterns in preleukemia and their clinical significance. Leuk Res. 1979;3(1):41–49. doi: 10.1016/0145-2126(79)90007-9. [DOI] [PubMed] [Google Scholar]
  63. Yunis J. J., Rydell R. E., Oken M. M., Arnesen M. A., Mayer M. G., Lobell M. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood. 1986 Jun;67(6):1721–1730. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES